Thermo Fisher Scientific
TMO
1,458 hedge funds and large institutions have $79.4B invested in Thermo Fisher Scientific in 2018 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 470 increasing their positions, 595 reducing their positions, and 74 closing their positions.
164% more first-time investments, than exits
New positions opened: 195 | Existing positions closed: 74
8% more funds holding in top 10
Funds holding in top 10: 118 → 128 (+10)
8% more funds holding
Funds holding: 1,350 → 1,458 (+108)
6% more call options, than puts
Call options by funds: $337M | Put options by funds: $318M
0.17% less ownership
Funds ownership: 88.28% → 88.12% (-0.17%)
9% less capital invested
Capital invested by funds: $86.9B → $79.4B (-$7.52B)
21% less repeat investments, than reductions
Existing positions increased: 470 | Existing positions reduced: 595
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$510M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$364M |
| 3 |
JP Morgan Chase
New York
|
+$307M |
| 4 |
BlackRock
New York
|
+$221M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$189M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Eagle Capital Management (New York)
New York
|
-$762M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$496M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
-$312M |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$268M |
| 5 |
GCM
Glenview Capital Management
New York
|
-$242M |
TMO Hedge Fund Activity: Q4 2018 in Review
1,458 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2018, worth a combined $79.4B — down 8.7% from $86.9B a quarter earlier.
Buyers outnumbered sellers: 195 funds opened new TMO positions and 74 closed out — a net gain of 121 holders — while 470 added to existing stakes and 595 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $510M. The largest seller was Eagle Capital Management (New York), cutting an estimated $762M.
- 1,458 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2018, up from 1,350 in Q3 2018.
- Funds reported $79.4B of Thermo Fisher Scientific stock for Q4 2018, down 8.7% quarter-over-quarter.
- 195 funds opened new Thermo Fisher Scientific positions in Q4 2018 and 74 closed out, a net change of +121 holders.
- The largest Thermo Fisher Scientific buyer in Q4 2018 was Fidelity Investments, an estimated $510M added.
- The largest Thermo Fisher Scientific seller in Q4 2018 was Eagle Capital Management (New York), an estimated $762M sold.
Based on aggregated 13F filings for Q4 2018.